Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2014-11-21

European Medicines Agency recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine)

View source ↗

Summary

EMA recommends measures to reduce risk of heart problems with ivabradine (Corlentor/Procoralan) including restricting use and monitoring due to potential heart-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corlentor (ivabradine hydrochloride)
  • Procoralan (Ivabradine)